Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 16, 2025

FDA accepts Chiesi triple combination inhaler application for asthma

Chiesi USA has announced the US Food and Drug Administration (FDA) acceptance for its New Drug Application (NDA) for triple combination inhaler for the maintenance treatment of asthma in adults.

Continue
The inhaler is to be administered twice daily using a pressurised metered-dose inhaler. Credit: CNordic Nordic on Unsplash.
November 11, 2025

Novartis opens California site for RLT manufacturing

The Carlsbad site is Novartis’ third US RLT manufacturing facility. Credit: Testalize.me on Unsplash
November 10, 2025

SanegeneBio and Lilly sign RNAi licence deal for metabolic diseases

SanegeneBio pipeline features experimental treatments for cardiometabolic conditions, kidney diseases and obesity. Credit: Photo by CDC on Unsplash.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz
  2. Leukogene Therapeutics gains FDA ODD status for M2T-CD33
  3. AmacaThera and Pacira sign agreement for AMT-143
  4. CNX Therapeutics expands CNS portfolio with Sativex acquisition
  5. Calluna secures FDA orphan drug designation for CAL101 in IPF

PRESS RELEASES

Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities
Gerresheimer at CPHI Frankfurt 2025
Gerresheimer at CPHI Frankfurt 2025
Pharmaceutical Business Review
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds

Suppliers

Whitepapers

Pharmaceutical Business Review
EVERIC® Pure – The Safe Option Right from the Start
Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme